ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Harkin Proposes To Add Another $400 Million To NCU Budget, Money To Come Forom Defense

July 26, 1991

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994